Cellular oxidative stress response mediates radiosensitivity in Fus1-deficient mice

Cell Death and Disease

Volumn 6, Issue 2, 2015, Pages

  Yazlovitskaya, E M ^a,b   Voziyan, P A ^a   Manavalan, T ^c   Yarbrough, W G ^c   Ivanova, A V ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; DNA; FUS1 PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; PYRIDOXAMINE; STAT3 PROTEIN; TEMPOL; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; SUPEROXIDE DISMUTASE; TUSC2 PROTEIN, MOUSE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRESS; CONTROLLED STUDY; DNA DAMAGE; DNA SYNTHESIS; ENZYME ACTIVITY; EPITHELIUM CELL; GASTROINTESTINAL TRACT; HOMEOSTASIS; INTESTINE CRYPT; INTESTINE INJURY; IONIZING RADIATION; IRRADIATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIOSENSITIVITY; ANIMAL; DEFICIENCY; FEMALE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; RADIATION RESPONSE; RADIATION TOLERANCE;

MUS;

ANIMALS; CYTOCHROMES C; DNA DAMAGE; FEMALE; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; RADIATION TOLERANCE; STAT3 TRANSCRIPTION FACTOR; SUPEROXIDE DISMUTASE; TUMOR SUPPRESSOR PROTEINS;

EID: 84927655971     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.593     Document Type: Article

References (30)

1. O'Neill P, Wardman P. Radiation chemistry comes before radiation biology. Int J Radiat Biol 2009; 85: 9-25.
2. Yoshida T, Goto S, Kawakatsu M, Urata Y, Li TS. Mitochondrial dysfunction, a probable cause of persistent oxidative stress after exposure to ionizing radiation. Free Radic Res 2012; 46: 147-153.
3. Yazlovitskaya EM, Uzhachenko R, Voziyan PA, Yarbrough WG, Ivanova AV. A novel radioprotective function for the mitochondrial tumor suppressor protein Fus1. Cell Death Dis 2013; 4: e687.
4. Potten CS. Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation. Nature 1977; 269: 518-521.
5. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol 2007; 8: 1007-1017.
6. Brown M. What causes the radiation gastrointestinal syndrome?: overview. Int J Radiat Oncol Biol Phys 2008; 70: 799-800.
7. Ivanova AV, Ivanov SV, Pascal V, Lumsden JM, Ward JM, Morris N et al. Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1. J Pathol 2007; 211: 591-601.
8. Uzhachenko R, Issaeva N, Boyd K, Ivanov SV, Carbone DP, Ivanova AV. Tumour suppressor Fus1 provides a molecular link between inflammatory response and mitochondrial homeostasis. J Pathol 2012; 227: 456-469.
9. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000; 60: 6116-6133.
10. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000; 60: 1949-1960.
11. Uzhachenko R, Ivanov S, Yarbrough WG, Shanker A, Medzhitov R, Ivanova AV. Fus1 is a novel regulator of mitochondrial calcium handling, Ca2+-coupled mitochondrial processes and Ca2+-dependent NFAT-and NFkB-pathways in CD4+ T cells. Antioxid Redox Signal 2013; 20: 1533-1547.
12. Ogawa Y, Kobayashi T, Nishioka A, Kariya S, Hamasato S, Seguchi H et al. Radiationinduced reactive oxygen species formation prior to oxidative DNA damage in human peripheral T cells. Int J Mol Med 2003; 11: 149-152.
13. Thotala D, Chetyrkin S, Hudson B, Hallahan D, Voziyan P, Yazlovitskaya E. Pyridoxamine protects intestinal epithelium from ionizing radiation-induced apoptosis. Free Radic Biol Med 2009; 47: 779-785.
14. Voziyan PA, Hudson BG. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage. Cell Mol Life Sci 2005; 62: 1671-1681.
15. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev 2008; 60: 418-469.
16. Thotala DK, Geng L, Dickey AK, Hallahan DE, Yazlovitskaya EM. A new class of molecular targeted radioprotectors: GSK-3beta inhibitors. Int J Radiat Oncol Biol Phys 2010; 76: 557-565.
17. Linkous AG, Yazlovitskaya EM, Hallahan DE. Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis. J Natl Cancer Inst 2010; 102: 1398-1412.
18. Negoro S, Kunisada K, Fujio Y, Funamoto M, Darville MI, Eizirik DL et al. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/ reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 2001; 104: 979-981.
19. Terui K, Enosawa S, Haga S, Zhang HQ, Kuroda H, Kouchi K et al. Stat3 confers resistance against hypoxia/reoxygenation-induced oxidative injury in hepatocytes through upregulation of Mn-SOD. J Hepatol 2004; 41: 957-965.
20. Haga S, Terui K, Zhang HQ, Enosawa S, OgawaW, Inoue H et al. Stat3 protects against Fasinduced liver injury by redox-dependent and-independent mechanisms. J Clin Invest 2003; 112: 989-998.
21. Hood MI, Uzhachenko R, Boyd K, Skaar EP, Ivanova AV. Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection. Infect Immun 2013; 81: 4461-4469.
22. Hosoki A, Yonekura S, Zhao QL, Wei ZL, Takasaki I, Tabuchi Y et al. Mitochondria-targeted superoxide dismutase (SOD2) regulates radiation resistance and radiation stress response in HeLa cells. J Radiat Res 2012; 53: 58-71.
23. Velayutham M, Hemann C, Zweier JL. Removal of H(2)O(2) and generation of superoxide radical: role of cytochrome c and NADH. Free Radic Biol Med 2011; 51: 160-170.
24. Pero RW, Anderson MW, Doyle GA, Anna CH, Romagna F, Markowitz M et al. Oxidative stress induces DNA damage and inhibits the repair of DNA lesions induced by N-acetoxy-2-acetylaminofluorene in human peripheral mononuclear leukocytes. Cancer Res 1990; 50: 4619-4625.
25. Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) 2002; 1: 3-25.
26. Salmon TB, Evert BA, Song B, Doetsch PW. Biological consequences of oxidative stressinduced DNA damage in Saccharomyces cerevisiae. Nucleic Acids Res 2004; 32: 3712-3723.
27. Pereboeva L, Westin E, Patel T, Flaniken I, Lamb L, Klingelhutz A et al. DNA damage responses and oxidative stress in dyskeratosis congenita. PLoS One 2013; 8: e76473.
28. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010; 15: 360-371.
29. Yan SX, Hong XY, Hu Y, Liao KH. Tempol one of nitroxides, is a novel ultraviolet-A1 radiation protector for human dermal fibroblasts. J Dermatol Sci 2005; 37: 137-143.
30. Ivanova AV, Ivanov SV, Prudkin L, Nonaka D, Liu Z, Tsao A et al. Mechanisms of FUS1/ TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects. Mol Cancer 2009; 8: 91.